MIR8067: A Potential Drug Target and Biomarker for Diseases (G102465869)
MIR8067: A Potential Drug Target and Biomarker for Diseases
MIR8067, also known as hsa-mir-8067, is a protein that is expressed in the human placenta and has been shown to play a role in the development and progression of various diseases, including cancer. The molecule has also been identified as a potential drug target and biomarker for several diseases.
MIR8067 is a type of transmembrane protein that is expressed in the placenta, which is the tissue that provides nutrients and oxygen to the developing fetus. It is made up of four transmembrane domains and a cytoplasmic tail. The cytoplasmic tail is involved in the formation of inclusion bodies, which are structures that can interact with and disrupt the activity of other proteins.
MIR8067 has been shown to be involved in several important biological processes, including cell signaling, angiogenesis, and placenta development. It has been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of MIR8067 are associated with an increased risk of preterm birth and low birth weight in pregnant women with gestational diabetes.
MIR8067 has also been shown to be a potential drug target and biomarker for several diseases, including cancer. For example, studies have shown that inhibiting the activity of MIR8067 can reduce the growth and survival of cancer cells. Additionally, MIR8067 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.
In addition to its potential as a drug target and biomarker, MIR8067 is also of interest as a potential therapeutic agent for the treatment of certain diseases. For example, studies have shown that MIR8067 can be administered to pregnant women with gestational diabetes to reduce the risk of preterm birth and low birth weight. Additionally, MIR8067 has been shown to be effective in treating certain types of cancer, such as breast cancer.
Overall, MIR8067 is a protein that has significant interest in the development and treatment of various diseases. Further research is needed to fully understand its role in these processes and to develop effective therapeutic agents for the treatment of these diseases.
Protein Name: MicroRNA 8067
More Common Targets
MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934 | MIR935 | MIR936 | MIR937 | MIR938 | MIR939 | MIR940 | MIR941-1 | MIR941-2 | MIR941-3 | MIR941-4 | MIR941-5 | MIR942 | MIR943 | MIR944 | MIR95 | MIR96 | MIR98 | MIR99A | MIR99AHG | MIR99B | MIRLET7 | MIRLET7A1 | MIRLET7A2 | MIRLET7A3 | MIRLET7B | MIRLET7BHG | MIRLET7C | MIRLET7D | MIRLET7E | MIRLET7F1 | MIRLET7F2 | MIRLET7G | MIRLET7I | MIS12 | MIS12 complex | MIS18A | MIS18A-AS1 | MIS18BP1 | MISFA | MISP | MISP3 | MITD1 | MITF | Mitochondrial complex I assembly complex | Mitochondrial import inner membrane translocase 23 (TIM23) complex | Mitochondrial inner membrane protease complex | Mitochondrial membrane ATP synthase | Mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) | Mitochondrial pyruvate carrier complex (MPC) | Mitochondrial RNA processing endoribonuclease | Mitofilin Complex | Mitofusin
